{"id":11106,"date":"2023-05-04T12:49:22","date_gmt":"2023-05-04T10:49:22","guid":{"rendered":"https:\/\/investmentbell.com\/?p=11106"},"modified":"2023-05-04T12:49:27","modified_gmt":"2023-05-04T10:49:27","slug":"regeneron-beats-quarterly-profit-estimates-on-eylea-strength","status":"publish","type":"post","link":"https:\/\/investmentbell.com\/ko\/news\/market-overview-news\/regeneron-beats-quarterly-profit-estimates-on-eylea-strength\/","title":{"rendered":"Regeneron beats quarterly profit estimates on Eylea strength"},"content":{"rendered":"<p>(Reuters) &#8211; Regeneron Pharmaceuticals Inc (NASDAQ:REGN) beat Wall Street estimates for first-quarter profit on Thursday, driven by strong demand for its blockbuster eye drug Eylea and eczema treatment Dupixent.<\/p>\n\n\n\n<p>Excluding items, the company reported a profit of $10.09 per share for the quarter, above analysts&#8217; estimates of $9.56, according to Refinitiv data.<\/p>\n<div class=\"rate-now\"><span id=\"rate-mypost11106\"><\/span> <span id=\"rate-points\"> 0<\/span><\/div>\n\t\t\t<script type=\"text\/javascript\">jQuery('#rate-mypost11106').raty({\n\t\t\t\thalfShow : true,\n\t\t\t\thalf: true,readOnly: true,score: 0,\n\t\t\t\tpath: \"https:\/\/investmentbell.com\/wp-content\/plugins\/userpro-rating\/images\/\"\n\t\t\t\t});<\/script>","protected":false},"excerpt":{"rendered":"<p>(Reuters) &#8211; Regeneron Pharmaceuticals Inc (NASDAQ:REGN) beat Wall Street estimates for first-quarter profit on Thursday, driven by strong demand for its blockbuster eye drug Eylea and eczema treatment Dupixent. Excluding items, the company reported a profit of $10.09 per share for the quarter, above analysts&#8217; estimates of $9.56, according to Refinitiv data. 0<\/p>","protected":false},"author":13,"featured_media":11107,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[89],"tags":[],"class_list":{"0":"post-11106","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-market-overview-news"},"_links":{"self":[{"href":"https:\/\/investmentbell.com\/ko\/wp-json\/wp\/v2\/posts\/11106","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/investmentbell.com\/ko\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/investmentbell.com\/ko\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/investmentbell.com\/ko\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/investmentbell.com\/ko\/wp-json\/wp\/v2\/comments?post=11106"}],"version-history":[{"count":0,"href":"https:\/\/investmentbell.com\/ko\/wp-json\/wp\/v2\/posts\/11106\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/investmentbell.com\/ko\/wp-json\/wp\/v2\/media\/11107"}],"wp:attachment":[{"href":"https:\/\/investmentbell.com\/ko\/wp-json\/wp\/v2\/media?parent=11106"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/investmentbell.com\/ko\/wp-json\/wp\/v2\/categories?post=11106"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/investmentbell.com\/ko\/wp-json\/wp\/v2\/tags?post=11106"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}